Spotlight

INN_new_section_spotlight2

In a newly-created section of this website, Sandoz explains why biosimilars must have the same International Non-Proprietary Name (INN) as the reference products.

Follow us

f_logo.jpg logo_youtube.jpg logo_twitter.jpg linkedin_internet.jpg

Healthcare Professionals

Portlet_HCPs

Biosimilar medicines offer physicians more choices at affordable prices thereby increasing patient access without increasing overall spending.

Payers

Portlet_Payers.jpg

Bending the curve of rising healthcare costs without compromising access to quality medical care for its citizens remains one of the most daunting challenges that governments are faced with.

Slideshow Background Images